Chronic Back Pain Clinical Trials 2023

What are the top hospitals conducting chronic back pain research?

Chronic back pain affects millions of individuals worldwide, causing immense discomfort and hindering their quality of life. Fortunately, hospitals at the forefront of medical innovation are dedicated to finding solutions for this prevalent condition. Mayo Clinic in Rochester leads the charge with four ongoing clinical trials focused on chronic back pain, building upon their impressive record of seven completed trials since pioneering research in this field began in 2005. In Chicago, Rush University Medical Center is making noteworthy contributions as well, currently conducting two active trials while having conducted six prior studies since undertaking its first chronic back pain trial in 2014.

Similarly committed to advancing knowledge and treatment options for chronic back pain are Vanderbilt University Medical Center in Nashville and the University of Colorado Anschutz Medical Campus in Aurora. Both institutions have two ongoing clinical trials targeting this condition and have collectively contributed to a total of twelve previous investigations since recording their initial trials respectively beginning only from 2017.

Additionally adding itself into remarkable efforts towards tackling Chronic Back Pain includes The University Of Pittsburgh where they're involved with various intriguing investigations consisting two current series focusing on it; while having successfully accomplished five experiments previously which were recorded from initiating their very first trial onwards tracing us only ten years ago to2011.These top-notch medical centers serve as beacons for individuals searching for effective treatments or even potential cures by tirelessly working towards unraveling the complexities surrounding chronic back pain through extensive research.

Despite being an often debilitating condition that affects countless individuals globally, these prominent hospitals offer hope through groundbreaking clinical trials that may revolutionize how we understand and treat chronic back pain. As each hospital contributes its unique expertise and resources towards combating this widespread issue, progress becomes not just a possibility but a reality on the horizon—improving lives one step at a time

Which are the best cities for chronic back pain clinical trials?

When it comes to chronic back pain clinical trials, several cities have emerged as leading hubs for research and development. New york City leads the way with 8 active trials exploring treatments such as Low Dose Tranexamic acid, Topical diclofenac, and Depo-Medrol 40Mg/Ml Suspension for Injection. Boston closely follows with 7 ongoing studies focused on interventions like CBD, Usual PCP care, and Oxycodone or morphine sulfate immediate release (MSIR). Rochester in Minnesota also stands out with 7 active trials investigating treatments like Angel® Concentrated Platelet Rich Plasma System and Antidepressants. These cities offer individuals suffering from chronic back pain access to cutting-edge clinical trials that hold promise for improved management of their condition.

Which are the top treatments for chronic back pain being explored in clinical trials?

Clinical trials are actively exploring various treatments for chronic back pain, aiming to provide much-needed relief. Among the frontrunners are:

• Physical Therapy, with 3 ongoing trials and a cumulative total of 13 chronic back pain trials since its introduction in 2011.
• Spinal Manipulation Therapy (SMT), currently being examined in 2 active clinical trials and having a record of 3 all-time chronic back pain studies since its first listing in 2018.
• T'ai Chi and Qigong Rehabilitation, showing promise with two ongoing trials and two previous chronic back pain studies listed from as early as 2022.
• ED Physical Therapy, also under investigation through two active clinical trials, joining the ranks with two all-time chronic back pain studies reported starting from 2021.

These innovative approaches offer hope for individuals burdened by the challenges posed by chronic back pain.

What are the most recent clinical trials for chronic back pain?

Recent clinical trials offer hope for individuals suffering from chronic back pain. One noteworthy trial explored the effectiveness of combining ibuprofen, dexamethasone, and educational intervention as a treatment approach. Another study investigated the Primary Spine Provider Model's potential to alleviate chronic back pain symptoms. Additionally, research focused on THC/CBD's role in managing this condition reached Phase 3. These trials represent significant strides towards improving the quality of life for those enduring chronic back pain and may lead to more effective treatments in the future.

What chronic back pain clinical trials were recently completed?

Recent advancements in the field of chronic back pain have been marked by the completion of several groundbreaking clinical trials. Notably, Scilex Pharmaceuticals, Inc., successfully concluded a trial for SP-103 therapy in April 2022. In October 2021, Eli Lilly and Company completed their LY3526318 trial, followed closely by the conclusion of their LY3556050 study in May 2021. Neurana Pharmaceuticals, Inc., also made significant progress by completing their Tolperisone Hydrochloride trial in December 2020. Lastly, Eli Lilly and Company achieved another milestone with the completion of their LY3016859 trial in August 2020. These trials represent important strides towards understanding and addressing chronic back pain to enhance patients' quality of life.